Is BioCryst Pharmaceuticals, Inc. (BCRX) a Buy, Sell, or Hold?
BioCryst Pharmaceuticals, Inc.
NASDAQ:BCRX
$9.74 USD
-$0.17 (-1.72%)
- Volume
- 4.48M
- Average Volume
- 5.05M
- Market Capitalization
- $2.04B
- P/E Ratio
- -5.63
- Dividend Yield
- 0.00%
- Price Target
- $17.00
- Year High
- $11.22
- Year Low
- $6.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.91
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-42.7% DOWNSIDE
$17.00 Price Target
UPSIDE/DOWNSIDE HIGH
-66.4% DOWNSIDE
$29.00 Price Target High
UPSIDE/DOWNSIDE LOW
-30.4% DOWNSIDE
$14.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Jefferies | Maury Raycroft | $17 | $9.55 | 2026-06-30 04:42 AM | 78.0% |
| JMP Securities | Jonathan Wolleben | $25 | $6.97 | 2025-11-05 05:41 AM | 258.7% |
| Jefferies | Maury Raycroft | $15 | $6.42 | 2025-10-14 03:21 PM | 133.6% |
| Barclays | Gena Wang | $7 | $7.51 | 2024-08-06 01:31 AM | -6.8% |
| Jefferies | Maury Raycroft | $11 | $7.51 | 2024-08-05 12:01 PM | 46.5% |